Cargando…

Cardioprotective Effects and Possible Mechanisms of Luteolin for Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Evidence

BACKGROUND: At present, effective clinical therapies for myocardial ischemia-reperfusion injury (MIRI) are lacking. We investigated if luteolin conferred cardioprotective effects against MIRI and elucidated the potential underlying mechanisms. METHOD: Four databases were searched for preclinical stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Qinyuan, Liu, Yang, Ma, Wenrui, Kan, Rongsheng, Zhu, Hong, Li, Dongye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081501/ https://www.ncbi.nlm.nih.gov/pubmed/35548432 http://dx.doi.org/10.3389/fcvm.2022.685998

Ejemplares similares

Preclinical multi-target strategies for myocardial ischemia-reperfusion injury
por: Li, Yuqing, et al.
Publicado: (2022)

PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury
por: Wei, Meng, et al.
Publicado: (2022)

Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis
por: Chen, Cong, et al.
Publicado: (2021)

Targeting Cell Signaling and Apoptotic Pathways by Luteolin: Cardioprotective Role in Rat Cardiomyocytes Following Ischemia/Reperfusion
por: Xu, Tongda, et al.
Publicado: (2012)

Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2018)

PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury
por: Nernpermpisooth, Nitirut, et al.
Publicado: (2021)

Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?
por: Chen, Cong, et al.
Publicado: (2022)

Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
por: Fernandez Rico, Carlota, et al.
Publicado: (2022)

Calpain: the regulatory point of myocardial ischemia-reperfusion injury
por: Liu, Guo-Yang, et al.
Publicado: (2023)

Luteolin Exerts Cardioprotective Effects through Improving Sarcoplasmic Reticulum Ca(2+)-ATPase Activity in Rats during Ischemia/Reperfusion In Vivo
por: Nai, Changsheng, et al.
Publicado: (2015)

Cardioprotective effects of shock wave therapy: A cardiac magnetic resonance imaging study on acute ischemia-reperfusion injury
por: Petrusca, Lorena, et al.
Publicado: (2023)

The Protective Effect of Sevoflurane Conditionings Against Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Trials in in-vivo Models
por: Hu, Bin, et al.
Publicado: (2022)

Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p
por: Bian, Chen, et al.
Publicado: (2015)

A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
por: Wang, Yifei, et al.
Publicado: (2023)

Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2017)

Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice
por: Hu, Ya, et al.
Publicado: (2020)

Association of GSDMD with microvascular-ischemia reperfusion injury after ST-elevation myocardial infarction
por: Sun, Wenjing, et al.
Publicado: (2023)

Heart rate reduction after genetic ablation of L-type Ca(v)1.3 channels induces cardioprotection against ischemia-reperfusion injury
por: Delgado-Betancourt, Viviana, et al.
Publicado: (2023)

Myocardial Ischemia-Reperfusion and Diabetes: Lessons Learned From Bedside to Bench
por: Dia, Maya, et al.
Publicado: (2021)

Cardioprotective effect of curcumin on myocardial ischemia/reperfusion injury: a meta-analysis of preclinical animal studies
por: Zeng, Yi-Fan, et al.
Publicado: (2023)

Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?
por: Barrère-Lemaire, Stéphanie, et al.
Publicado: (2022)

Effect and possible mechanisms of saponins in Chinese herbal medicine exerts for the treatment of myocardial ischemia-reperfusion injury in experimental animal: a systematic review and meta-analysis
por: Sun, Jiahao, et al.
Publicado: (2023)

Influence of Intrinsic Aerobic Exercise Capacity and Sex on Cardiac Injury Following Acute Myocardial Ischemia and Reperfusion
por: Alsahly, Musaad B., et al.
Publicado: (2021)

Ginsenoside Rg2 Ameliorates Myocardial Ischemia/Reperfusion Injury by Regulating TAK1 to Inhibit Necroptosis
por: Li, Yao, et al.
Publicado: (2022)

Renal Denervation Attenuates Adverse Remodeling and Intramyocardial Inflammation in Acute Myocardial Infarction With Ischemia–Reperfusion Injury
por: Wang, Kun, et al.
Publicado: (2022)

Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021)

Myocardial oxidative stress is increased in early reperfusion, but systemic antioxidative therapy does not prevent ischemia-reperfusion arrhythmias in pigs
por: Haugsten Hansen, Marie, et al.
Publicado: (2023)

Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits—demonstration of cardioprotection with rapamycin
por: Samidurai, Arun, et al.
Publicado: (2021)

Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies
por: Wei, Xin-Yu, et al.
Publicado: (2023)

Oral Supplementation With Butyrate Improves Myocardial Ischemia/Reperfusion Injury via a Gut-Brain Neural Circuit
por: Yu, Zhiyao, et al.
Publicado: (2021)

Electroacupuncture Pretreatment Mitigates Myocardial Ischemia/Reperfusion Injury via XBP1/GRP78/Akt Pathway
por: Wang, Nisha, et al.
Publicado: (2021)

Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II
por: Kumphune, Sarawut, et al.
Publicado: (2023)

A new method for the treatment of myocardial ischemia-reperfusion injury based on γδT cell-mediated immune response
por: Luo, Wei, et al.
Publicado: (2023)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023)

Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms
por: Huang, Yue-yue, et al.
Publicado: (2018)

Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
por: Wohlfart, Paulus, et al.
Publicado: (2013)

Cardioprotective Effect of Betulinic Acid on Myocardial Ischemia Reperfusion Injury in Rats
por: Xia, Anzhou, et al.
Publicado: (2014)

Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection
por: Liu, Nan-Bo, et al.
Publicado: (2019)

Bilateral Superior Cervical Sympathectomy Activates Signal Transducer and Activator of Transcription 3 Signal to Alleviate Myocardial Ischemia-Reperfusion Injury
por: Li, Lixia, et al.
Publicado: (2022)

Maslinic Acid Attenuates Ischemia/Reperfusion Injury-Induced Myocardial Inflammation and Apoptosis by Regulating HMGB1-TLR4 Axis
por: Li, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8v09oduvio8ohul3g8e87m2f2